scholarly journals Evidence for Ethylene-Vinyl-Alcohol-Copolymer Liquid Embolic Agent as a Monotherapy in Treatment of Endoleaks

2016 ◽  
Vol 51 (6) ◽  
pp. 810-814 ◽  
Author(s):  
R.W. Jamieson ◽  
P. Bachoo ◽  
A.L. Tambyraja
Keyword(s):  
Vinyl Alcohol ◽  
Embolic Agent ◽  
Ethylene Vinyl Alcohol ◽  
Ethylene Vinyl Alcohol Copolymer ◽  
Liquid Embolic ◽  
Liquid Embolic Agent

scholarly journals Single institutional experience of peripheral applications of a liquid embolic agent: Ethylene Vinyl Alcohol Copolymer

2020 ◽  
Vol 3 (1) ◽  
Author(s):  
Abhijit L. Salaskar ◽  
Faezeh Razjouyan ◽  
Alexander L. Cho ◽  
Rishi R. Sood ◽  
Andrew Akman ◽  
...  
Keyword(s):  
Vinyl Alcohol ◽  
Embolic Agent ◽  
Ethylene Vinyl Alcohol ◽  
Ethylene Vinyl Alcohol Copolymer ◽  
Liquid Embolic ◽  
Institutional Experience ◽  
Liquid Embolic Agent

Transcatheter Embolization of a Pancreatic Pseudoaneurysm Using a New Liquid Embolic Agent, Ethylene Vinyl Alcohol Copolymer (Onyx)

Pancreas ◽  
2009 ◽  
Vol 38 (1) ◽  
pp. 110-112 ◽  
Author(s):  
Antonia Brox Jiménez ◽  
Pablo Parra Membrives ◽  
Daniel Díaz Gómez ◽  
José González Herráez ◽  
Jorge Haurie Girelli ◽  
...  
Keyword(s):  
Vinyl Alcohol ◽  
Transcatheter Embolization ◽  
Embolic Agent ◽  
Ethylene Vinyl Alcohol ◽  
Ethylene Vinyl Alcohol Copolymer ◽  
Liquid Embolic ◽  
Liquid Embolic Agent

scholarly journals A Nonadhesive Liquid Embolic Agent of Ethylene Vinyl Alcohol Copolymer and Ethanol Mixture for Cerebral Arteriovenous Malformations

2004 ◽  
Vol 10 (1_suppl) ◽  
pp. 135-142 ◽  
Author(s):  
JI Hamada ◽  
Y. Kai ◽  
T. Mizuno ◽  
M. Morioka ◽  
K. Kazekawa ◽  
...  
Keyword(s):  
Vinyl Alcohol ◽  
Arteriovenous Malformations ◽  
Neurological Deficits ◽  
Embolic Agent ◽  
Preoperative Embolization ◽  
Ethanol Mixture ◽  
Ethylene Vinyl Alcohol ◽  
Ethylene Vinyl Alcohol Copolymer ◽  
Liquid Embolic ◽  
Liquid Embolic Agent

We report our experience using our new nonadhesive liquid embolic agent, an ethylene vinyl alcohol copolymer (EVAL)/Ethanol mixture, to treat human arteriovenous malformations (AVM). Between June 1995 and April 2001, 57 patients with confirmed AVM underwent embolization with the EVAL/Ethanol mixture. Using 87 procedures consisting of one to three stages, we embolized 185 feeding arteries to occlude as much of the AVM as possible. Repeated injections under fluoroscopic control could be performed smoothly without encountering cementing of the catheter in the vessel wall. Among 87 procedures undertaken in 57 patients, seven (8.0%) procedures in six patients produced new postembolization symptoms. Resolution of these symptoms occurred within hours or days following four of the seven procedures; permanent neurological deficits remained after three embolization procedures (3.4%). Of the 57 patients, three underwent postembolization radiosurgery, 54 were radically treated with microsurgical extirpation. Histopathological examinations of the 54 specimens disclosed mild inflammation within the embolized lumen without inflammatory reactions in the media or adventitia. Follow-up angiograms obtained three years after they underwent radiosurgery showed that in all three patients the nidus had completely disappeared. The EVAL/Ethanol mixture is handled easily and appears to be an effective and safe embolic agent for the preoperative embolization of AVM.

A mixture of ethylene vinyl alcohol copolymer and ethanol yielding a nonadhesive liquid embolic agent to treat cerebral arteriovenous malformations: initial clinical experience

2002 ◽  
Vol 97 (4) ◽  
pp. 881-888 ◽  
Author(s):  
Jun-Ichiro Hamada ◽  
Yutaka Kai ◽  
Motohiro Morioka ◽  
Kiyoshi Kazekawa ◽  
Yasuji Ishimaru ◽  
...  
Keyword(s):  
Clinical Experience ◽  
Vinyl Alcohol ◽  
Arteriovenous Malformations ◽  
Embolic Agent ◽  
Ethanol Mixture ◽  
Content Type ◽  
Ethylene Vinyl Alcohol ◽  
Liquid Embolic ◽  
Liquid Embolic Agent ◽  
Fine Print

Object. The authors report their clinical experience with their new nonadhesive liquid embolic agent, an ethylene vinyl alcohol copolymer (EVAL)/ethanol mixture, to treat arteriovenous malformations (AVMs). Methods. Between June 1995 and April 2001, 57 patients with confirmed AVMs underwent embolization of their lesions with the EVAL/ethanol mixture. In 87 procedures consisting of one to three stages, the authors embolized 185 feeding arteries to occlude as much of the AVM as possible. Repeated injections under fluoroscopic control could be performed smoothly without encountering cementing of the catheter to the vessel wall. Among the 87 embolizations undertaken in 57 patients, seven procedures (8%) in six patients produced new postembolization symptoms. Resolution of these symptoms occurred within hours or days after four of the seven procedures; permanent neurological deficits remained after the other three procedures (3.4%). Of the 57 patients, three underwent postembolization radiosurgery, and 54 underwent radical treatment with microsurgical extirpation. Histopathological examination of the 54 specimens disclosed mild inflammation within the embolized lumen without inflammatory reactions in the media or adventitia. Follow-up angiograms obtained 3 years after radiosurgery was administered showed that in all three patients treated in this fashion the nidus had completely disappeared. Conclusions. The EVAL/ethanol mixture is handled easily and appears to be an effective and safe agent for preoperative embolization of AVMs.

Sign in / Sign up

Export Citation Format

Share Document